Hyperthyroidism in pregnancy

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 18, Issue 2, 2004, Pages 267-288

  Metsman, Jorge H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antithyroid drugs; Graves' disease; Hyperthyroidism

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHYROID AGENT; ATENOLOL; CARBIMAZOLE; CHORIONIC GONADOTROPIN; DIGOXIN; ESMOLOL; HORMONE ANTIBODY; HYDROCORTISONE; IODINE 131; LABETALOL; LEVOTHYROXINE; PARACETAMOL; PROPRANOLOL; PROPYLTHIOURACIL; SODIUM IODIDE; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROID EXTRACT; THYROTROPIN; THYROXINE;

ADULT; AGRANULOCYTOSIS; ANTIBODY TITER; BREAST FEEDING; CHOANA ATRESIA; CLINICAL FEATURE; CONCEPTION; CONGESTIVE HEART FAILURE; CONTRACEPTION; DIFFERENTIAL DIAGNOSIS; DRUG ERUPTION; DRUG HALF LIFE; DRUG PENETRATION; ESOPHAGUS ATRESIA; EYE DISEASE; FEMALE; FETUS DISEASE; FEVER; FREE THYROXINE INDEX; GINGIVITIS; GOITER; GRAVES DISEASE; HUMAN; HYPERPYREXIA; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; LABORATORY DIAGNOSIS; LOW BIRTH WEIGHT; MALAISE; MATERNAL HYPERTENSION; MUSCLE WEAKNESS; NEWBORN DISEASE; NEWBORN MORBIDITY; OBSTRUCTIVE JAUNDICE; POLYARTHRITIS; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRURITUS; PUERPERIUM; REVIEW; SKIN APLASIA; SORE THROAT; SPONTANEOUS ABORTION; STILLBIRTH; SYMPTOMATOLOGY; TACHYCARDIA; TERATOGENICITY; THYROID CRISIS; THYROIDECTOMY; THYROTOXICOSIS; WEIGHT REDUCTION;

EID: 3042579843     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2004.03.005     Document Type: Review

References (88)

1. Mestman JH. Thyroid diseases in pregnancy. Clinical Obstetrics and Gynecology, vol. 40. Philadelphia: Lippincott/Raven, 1997.
2. Schlumberger M, Vathaire F, Ceccarelli C, et al. Exposure to radioactive iodine 131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. Journal of Nuclear Medicine 1996; 37: 606-612.
3. Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congential malforation of the offspring. Clinical Endocrinology 1984; 20: 695-700.
4. Tamaki H, Itoh E, Kaneda T, et al. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease. Thyroid 1993; 3: 189-193.
5. Mandel SL, Larsen PR, Seely EW, et al. Incrased need for thyroxine during pregnancy in women with primary hypothyroidism. New England Journal of Medicine 1990; 323: 91.
6. Kaplan MM. Management of women on thyroxine therapy during pregnancy. Endocrine Practice 1996; 2: 281-286.
7. Polak M. Hyperthyroidism in early infancy: pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism. Thyroid 1998; 8: 1171-1177.
8. Kopp P, Van Sande J, Parma J, et al. Brief report: congenital hyperthyroidism caused by a mutaton in the thyrotropin receptor gene. New England Journal of Medicine 1995; 322: 150-154.
9. Momotani N, Noh J, Ishikawa N, et al. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period. Journal of Clinical Endocrinology and Metabolism 1994; 79: 285-289.
10. Burrow GN. Thyroid function and hyperfunction during gestation. Endocrine Reviews 1993; 14: 194-202.
11. Goodwin TM & Hershman JM. Hyperthyroidism due to inappropriate production of human chorioinic gonadotropin. Clinical Obstetrics and Gynecology 1997; 40: 32-44.
12. Caffrey T. Transient hyperthyroidism of hyperemesis gravidarum: a sheep in wolf's clothing. Journal of the American Board of Family Practice 2000; 13: 35-38.
13. Caron P, Gerbeau C & Pradayroi L. Maternal-fetal transfer of octreotide. New England Journal of Medicine 1995; 333: 601-602.
14. Kung AWC, Ma JTC, Wang C & Young RTT. Hyperthyroidism during pregnancy due to coextistence of struma ovarii and Graves' disease. Postgraduate Medical Journal 1990; 66: 132-133.
15. Gardiner-Hill H. Pregnancy complicating simple goiter and Graves' disease. Lancet 1929; 1: 120-124.
16. McLaughlin CW & McGoogan LS. Hyperthyroidism complicating pregnancy. American Journal of Obstetrics and Gynecology 1943; 45: 591-603.
17. Means JH. The Thyroid and its Diseases. Philadelphia, PA: Lippincott, 1937.
18. Astwood EB. The use of antithyroid drugs during pregnancy. Journal of Clinical Endocrinology 1951; 10: 1045-1056.
19. Piper J & Rosen J. Management of hyperthyroidism during pregnancy. Acta Medica Scandinavica 1954; 150: 215-222.
20. Hawe P & Crances HH. Pregnancy and thyrotoxicosis. British Medical Joumal 1962; : 817-822.
21. Selenkow HA. Therapeutic considerations for thyroxtocosis during pregnancy. In Fisher DA & Burrow GN (eds) Perinatal Thyroid Physiology and Disease. New York: Raven Press, 1975, pp 145-161.
22. Mestman JH, Manning PR & Hodgman J. Hyperthyroidism and pregnancy. Archives of Internal Medicine 1974; 134: 434.
23. Daniels GH. Thyroid disease in pregnancy: a clinical review. Endocrine Practice 1995; 1: 287-301.
24. Roti E, Minelli R & Salvi M. Clinical review 80: management of hyperthyroidism and hypothyroidism in the pregnant woman. Journal of Clinical Endocrinology and Metabolism 1996; 81: 1679-1682.
25. Hamburger JI. Diagnosis and management of Graves' disease in pregnancy. Thyroid 1992; 2: 219-224.
26. Lamberg BA, Ikonen E, Teramo K, et al. Treatment of maternal hyperthyroidism with antithyroid agents and changes in thyrotropin and thyroxine in the newborn. Acta Endocrinologica 1981; 97: 186-195.
27. Watanabe M, Iwatani Y, Kaneda T, et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. American Journal of Reproductive Immunology 1997; 37: 368-377.
28. Kung AWC & Jones BM. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. Journal of Clinical Endocrinology and Metabolism 1998; 83: 514-518.
29. Davis LE, Lucas MJ, Hankins GDV, et al. Thyrotoxicosis complicating pregnancy. American Journal of Obstetrics and Gynecology 1988; 160: 63-70.
30. Millar LK, Wing DA, Leung AS, Koonings PP, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstetrics and Gynecology 1994; 84: 946-949.
31. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clinical Endocrinology 2001; 54: 365-370.
32. Klein I & Levey GS. The cardiovascular system in thyrotoxocosis. In Braverman LE & Utiger RD (eds) Werner and Ingbar's The Thyroid, 8th edn. Philadelphia: Lippincott/Williams & Wilkins, 2000, pp 596-604.
33. Belfiore A, Garofalo MR, Guiffrida D, et al. Increased aggressiveness of thyroid cancer in patients with Graves' disease. Journal of Clinical Endocrinology and Metabolism 1990; 70: 830-835.
34. Brent GA:. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clinical Obstetrics and Gynecology 1997; 40: 3-15.
35. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocrine Reviews 1997; 18: 404-433.
36. McKenzie JM & Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992; 2: 155.
37. Javert CT. Hyperthyroidism and pregnancy. American Journal of Obstetrics and Gynecology 1940; 39: 954-963.
38. Herbst AL & Selenkow HA. Hyperthyroidism during pregnancy. New England Journal of Medicine 1965; 273: 627-633.
39. Momotani N, Noh J, Oyangi H, et al. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. New England Journal of Medicine 1986; 315: 24.
40. Clark SL, Phelan JP, Montoro MN, et al. Transient ventricular dysfunction associated with cesarean section in a patient with hyperthyroidism. American Journal of Obstetrics and Gynecology 1985; 151: 384.
41. Easterline TR, Schumacker BC, Carlson KL, et al. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstetrics and Gynecology 1991; 78: 348-352.
42. Mestman JH. Severe hyperthyroidism in pregnancy. In Clark SL, Cotton DB, Hankins GDV & Phelan JP (eds) Critical Care Obstetrics, 2nd edn. London: Blackwell Scientific Publications, 1991, pp 307-328.
43. Mestman JH, Goodwin TM & Montoro MN. Thyroid disorders in pregnancy. Endocrinology and Metabolism Clinics of North America 199S; 24: 41.
44. Mitsuada N, Tamaki H, Amino N, Hosono T, Miyai K & Tanizawa O. Risk factors for developmental disorders in infants born to women with Graves' disease. Obstetrics and Gynecology 1992; 80: 359-364.
45. Momatani N & Ito K. Treatment of pregnant patients with Basedow's disease. Experimental and Clinical Endocrinology 1991; 97: 268-274.
46. Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and prophylthiouracil equally cross the perfused human term placental lobule. Journal of Clinical Endocrinology and Metabolism 1997; 82: 3099-3102.
47. Wing DA, Miller LK & Koonings PP. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. American Journal of Obstetrics and Gynceology 1994; 170: 90-95.
48. Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 1997; 82: 3633-3636.
49. Mujtaba Q & Burrow GN. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole. Obstetrics and Gynecology 1975; 3: 282-286.
50. Mandel SK, Brent GA & Larsen PR. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis. Thyroid 1994; 4: 129-133.
51. Van Dikje CP, Heydendael RJ & De Kleine MJ. Methimazole, carbimazole and congenital skin defects. Annals of Internal Medicine 1987; 106: 60.
52. Ramirez A, Espinosa de los Monteros A, Parra A & Deleon B. Esophageal atresia and tracheoesophageal fistula in two infants born to hyperthyroid women receiving methimazole during pregnancy. American Journal of Medical Genetics 1992; 44: 200-202.
53. Clementi M, Di Gianaantonio E, Pelo E, Mammi I, et al. Methimazole embryopathy: delineation of the phenotype. American Journal of Medical Genetics 1999; 83: 43-46.
54. Di Gianantonio E, Schaefer C, Mastroiacovo P, et al. Adverse effects of prenatal methimazole exposure. Teratology 2001; 64: 262-266.
55. Karlsson FA. Severe embryopathy and exposure to methimazole in early pregnancy. Journal of Clinical Endocrinology and Metabolism 2002; 87: 947-948.
56. Mandel SJ & Cooper DS. The use of antithyroid drugs in pregnancy and lactation. Journal of Clinical Endocrinology and Metabolism 2001; 86: 2354-2359.
57. Cooper DS. Propylithiouracil levels in hyperthyroid patients unresponsive to large disease. Annals of Internal Medicine 1985; 192: 328.
58. Cheron RG, Kaplan MM, Larsen PR, et al. Neonatal thyroid function after propylthiouracil therapy for maternal Graves' disease. New England Journal of Medicine 1981; 304: 525.
59. Cooper DS, Golminz D, Levin AA, et al. Agranulocytosis associated with antithyroid drugs: effects of patient's age and drug dose. Annals of Internal Medicine 1983; 98: 26-29.
60. Burrow GN, Bartsocas C, Klatsjin EH, et al. Children exposed in utero to propylthiouracil. American Journal of Disease in Childhood 1968; 116: 161-165.
61. McCarroll GN, Hutchinson M, Mc Auley R, et al. Long term assessment of children exposed in utero to carbimazole. Archives of Disease in Childhood 1976; 51: 532-536.
62. Eisenstein Z, Weiss M, Katz A & Bank H. Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. European Journal of Pediatrics 1992; 151: 558-559.
63. Sherif IH, Dyan WT, Basairi S, et al. Treatment of hyperthyroidism in pregnancy. Acta Obstetricia et Gynecologica Scandinavica 1991; 70: 461-463.
64. Bowman MI, Bergmann M & Smith JF. Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid 1988; 8: 795-796.
65. Bruner J, Landon MB & Gabbe SG. Diabetes mellitus and Graves' disease in pregnancy complicated by maternal allergies to antithyroid medication. Obstetrics and Gynecology 1988; 72: 443-445.
66. Borras-Perez MV, Moreno-Perez D, Zuasnabar-Cotro A & Lopez-Siguero JP. Neonatal hyperthyroidism in infants of mothers previously thyroidectomized due to Graves' disease. Journal of Pediatric Endocrinology 2001; 14: 1169-1172.
67. Stoffer SS & Hamburger JI. Inadvent 131I therapy for hyperthyroidism in the first trimester of pregnancy. Journal of Nuclear Medicine 1976; 17: 146.
68. Evans PMS, Webster J, Evans WD, et al. Radioiodine treatments in unsuspected pregnancy. Clinical Endocrinology 1998; 48: 281-283.
69. Galina MP, Avnet NL & Einhorn A. Iodines during pregnancy: an apparent cause of neonatal death. New England Journal of Medicine 1962; 267: 1124-1127.
70. Momotani N, Hisaoka T, Noh J, et al. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. Journal of Clinical Endocrinology and Metabolism 1992; 75: 738-744.
71. Singer PA & Mestman JH. Thyroid storm need not be lethal. Contemperory Obstetrics and Gynecology 1983; 98: 135-145.
72. Tiergens ST & Leinung MC. Thyroid storm. Medical Clinics of North America 1995; 79: 169.
73. Dussault JH. Neonatal screening for congenital hypothyroidism. Clinics in Laboratory Medicine 1993; 13: 645-652.
74. Goluboff LG, Sisson JC & Hamburger JI. Hyperthyroidism associated with pregnancy. Obstetrics and Gynecology 1974; 44: 107-116.
75. Gardner DF, Cruikshank SP, Hays PM, et al. Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: coreclation of maternal PTU concentrations with cord serum thyroid function tests. Journal of Clinical Endocrinology and Metabolism 1986; 62: 217-220.
76. Abuhamad AZ, Fisher DA, Warsot SL, et al. Antenatal diagnosis and treatment of fetal goitrous hypothyroidism: case report and review of the literature. Ultrasound Obstetrics and Gynecology 1995; 6: 368-371.
77. Van Herle AJ, Young RT, Fisher DA, et al. Intrauterine treatment of a hypothyroid fetus. Journal of Clinical Endocrinology and Metabolism 1975; 40: 474-477.
78. Peleg D, Cada S, Peleg A & Ben-Ami M. The relationship between maternal serum thyroid stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstetrics and Gynecology 2002; 99: 1040-1043.
79. Mandel SH, Hanna CE & LaFranci SH. Neontal hypopituitary hypothyroidism associated with maternal thyrotoxicosis. Journal of Pediatric Endocrinology 1989; 3: 189-192.
80. Kempers MJE, van Tijn DA, van Trotsenburg ASP, et al. Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. Journal of Clinical Endocrinology and Metabolism 2003; 88: 5851-5857.
81. Perelman AH, Johnson RL, Clemons RD, et al. Intrauterine diagnosis and treatment of fetal goitrous hypothyroidism. Journal of Clinical Endocrinology and Metabolism 1990; 71: 618-621.
82. Heckel S, Favre R, Schlienger JL, et al. Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. Fetal Diagnosis and Therapy 1997; 12: 54-58.
83. Nachum Z, Rakover Y, Weiner E & Shalev E. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Obstetrics and Gynecology 2003; 189: 159-165.
84. Kilpatrick S. Umbilical blood sampling in women with thyroid disease in pregnancy: is it necessary? Obstetrics and Gynecology 2003; 189: 1-2.
85. Amino N, Tanizawa O, Mori H, Iwatani Y, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. Journal of Clinical Endocrinology and Metabolism 1982; 55: 108-112.
86. Cooper DS. Which antithyroid drug? American Journal of Medicine 1986; 80: 1165-1168.
87. Momotani N, Yamashita R, Yoshimoto M, et al. Recovery from foetal hypothyroidism: evidence for the safety of breastfeeding while taking propylthiouracil. Clinical Endocrinology 1989; 31: 591-595.
88. Azizi F, Khoshniat M, Bahrainian M & Hedayati M. Thyroid function and intellectual development of intants nursed by mothers taking methimazole. Journal of Clinical Endocrinology and Metabolism 2000; 85: 3233-3238.